Fresenius Medical Care Ag · XETR:FME
Fresenius Medical Care — Shareholder Meeting (May 2015)
19 slides from Fresenius Medical Care's shareholder meeting presentation, May 19, 2015
Slide 1: Annual General Meeting 2015
Annual General Meeting 2015 Frankfurt | May 19, 2015 Rice Powell Chief Executive Officer and Chairman of the Management Board
Slide 2: Welcome
Rice Powell CEO WELCOME Frankfurt | May 19, 2015
Slide 3: Agenda
Agenda 1. Looking back at the year 2014 2. Current business performance 3. Growth strategy and long-term goals © | Annual © | Hauptversammlung General Meeting 2015 3
Slide 4: Looking back – the 2014 goals achieved
Looking back – the 2014 goals achieved Highlights Results in $ billions 15.83 14.61 +8% Record sales Net income REVENUE in Fresenius Medical slightly below the Care’s history results in 2013 2013 2014 2.26 2.25 EBIT Cost savings 2013 2014 of around 65 m $ (40 m $ after tax) slightly above our 1.11 1
Slide 5: Fresenius Medical Care today
Fresenius Medical Care today ~ 40 3.6 bn $ One in 2 ~ 3,400 Production Revenue dialysis machines clinics facilities dialysis products come from throughout the Fresenius world Medical Care > 286 thsd ~ 43 million 11.2 ~ 1 bn $ patients dialysis bn $ Revenue treatments Revenue Care dialysis services C
Slide 6: 2014 – Revenue trends in the regions
2014 – Revenue trends in the regions North America Asia-Pacific Revenue 10,500 m $ +9% Revenue 1,357 m $ +26%cc Europe Latin America Revenue 3,072 m $ +4%cc Revenue 836 m $ +16%cc 5% Latin America 4 9% 3 Asia-Pacific 2 15,832 $ millions +10%cc 1 20% 66% Europe North America cc = constant currency ©
Slide 7: 18th consecutive dividend increase
18th consecutive dividend increase Highlights Dividend per share in € +1% Dividend Dividend payout ratio payout 0.77 0.78 of 30% will amount to 237 m € 0.17 1997 2013 2014 © | Annual General Meeting 2015 7
Slide 8: Performance of the share price
Performance of the share price Share price performance Total return 2004 to 2014 – May 15, 2014 to May 19, 2015 average annual performance % 180 Fresenius 160 +58% 14% Medical Care 140 120 +21% 100 DAX-Index 9% 80 May 15, May 19, 2014 2015 With a share price increase of 58% the Fresenius Medical Car
Slide 9: 2020 growth strategy
2020 growth strategy Growing in our Opening up core business new business areas Enhancing Increasing products and efficiency treatments and flexibility © | Annual General Meeting 2015 9
Slide 10: Development of dialysis patient numbers
Development of dialysis patient numbers The increasing number of patients worldwide will result in a growth in our core business 4000000 CAGR 6.2 % 3500000 3000000 CAGR 6.8 % 2500000 2000000 1500000 1000000 500000 0 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97
Slide 11: Opening up new business areas
Opening up new business areas Care Coordination Examples Vascular care Cardiovascular and endovascular specialty services Hospitalists and intensivists Pharmacy (Rx) Laboratory © | Annual General Meeting 2015 11
Slide 12: Innovative and high-quality products
Innovative and high-quality products Since the seventies Our latest products Fresenius Medical Care has set the quality in acute therapy and home dialysis take up standard in dialysis the story of success © | Annual General Meeting 2015 12
Slide 13: Increasing efficiency
Increasing efficiency In 2013 launch of the Global Efficiency Program Aim reduce costs and increase income in a sustainable way Global In 2014 Efficiency cost savings of 65 m $ before tax achieved Program By the end of 2016 efficiency gains should increase to 300 m $ a year © | Annual General Meetin
Slide 14: Outlook
Outlook 2015e 2016 projection in $ millions 10-12%cc 9-12%cc Revenue 5-7% 9-12% Net income 0-5% 15-20% Information includes savings from the Global Efficiency Program The outlook is based on the execution and the operating cost investments within the Care Coordination business Potential acquis
Slide 15: Long-term goals up to 2020
Long-term goals up to 2020 2015 – 2020 average growth rates p.a. 28.0 bn $ Revenue ~10% 15.8 bn $ Net income 4.2 bn $ high single digit (%) 2000 2014 2020 Services Products Care Coordination © | Annual General Meeting 2015 15
Slide 16: Agenda of the Annual General Meeting
Agenda of the Annual General Meeting Items 1 to 5 Usual resolutions Item 6 Flexibilization and expansion of the corporate objectives Item 7 Renew the expiring authorized capital Item 8 Reduce the carrying majority required for supervisory board votes to a simple majority © | Annual General Meeting 2
Slide 17: Thank you very much for your attention!
CREATING A FUTURE WORTH LIVING. FOR PATIENTS. WORLDWIDE. EVERY DAY. Thank you very much for your attention! © | Annual General Meeting 2015 17
Slide 18: Annual General Meeting 2015
Annual General Meeting 2015 Frankfurt | May 19, 2015 Rice Powell Chief Executive Officer and Chairman of the Management Board
Slide 19: Safe Harbor Statement
Safe Harbor Statement: This presentation includes certain forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Act of 1934, as amended. The Company has based these forward-looking statements on its views w
Fresenius Medical Care — Shareholder Meeting (May 2015) on 6ix